Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sebclair is a non-steroidal topical medical device available as a cream or shampoo, primarily indicated for the management and relief of symptoms associated with seborrheic dermatitis (SD), including itching, burning, scaling, and pain. It is also used for cradle cap in infants, which is a form of seborrheic dermatitis. The product functions through a multimodal approach, combining antimycotic, anti-inflammatory, and keratolytic properties. Its formulation aims to restore normal skin barrier function by promoting moisture retention and normalizing skin physiology. Key active ingredients include Piroctone Olamine for its antifungal action, Alglycera (a complex of Allantoin and Glycyrrhetinic Acid) for non-steroidal anti-inflammatory and keratolytic effects, Bisabolol for anti-inflammatory, antioxidant, and soothing properties, and Telmesteine for its antioxidant and skin barrier repairing capabilities. Other ingredients like Lactic Acid and Malic Acid provide exfoliating benefits, while various vitamins and plant extracts contribute antioxidant and moisturizing effects. Sebclair is designed to be effective without the rebound effects often associated with topical corticosteroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sebclair.